Cargando…
Tranexamic acid reduces blood cost in long-segment spinal fusion surgery: A randomized controlled study protocol
OBJECTIVE: Long-segment spinal fusion surgery was associated with substantial perioperative blood loss which may increase hospitalization expenses and mortality rates. Substantial studies have reported that tranexamic acid (TXA) could reduce blood products and cost after joint arthroplasty surgery....
Autores principales: | Yang, Linyu, Jia, Xufeng, Yang, Jian, Kang, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489668/ https://www.ncbi.nlm.nih.gov/pubmed/32925743 http://dx.doi.org/10.1097/MD.0000000000022069 |
Ejemplares similares
-
Topical use of tranexamic acid can effectively decrease hidden blood loss during posterior lumbar spinal fusion surgery: A retrospective study
por: Ren, Zhinan, et al.
Publicado: (2017) -
Tranexamic acid reduces blood cost in long-segment spinal fusion surgery: a randomized controlled study protocol: Retraction
Publicado: (2022) -
Intravenous versus topical tranexamic acid in lumbar interbody fusion: A protocol of randomized controlled trial
por: Song, Fei, et al.
Publicado: (2020) -
Tranexamic acid reduces blood cost in long-segment spinal fusion surgery: A randomized controlled study protocol: Partial Retraction
Publicado: (2021) -
The efficacy of tranexamic acid in reducing blood loss in total shoulder arthroplasty: A meta-analysis
por: He, Jing, et al.
Publicado: (2017)